• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthResearch

Wharton researchers think a specific text message could be key to getting more people vaccinated

By
Lee Clifford
Lee Clifford
Executive Editor
Down Arrow Button Icon
By
Lee Clifford
Lee Clifford
Executive Editor
Down Arrow Button Icon
February 20, 2021, 9:00 AM ET

It’s called a “behavioral nudge.”

A small action that prompts the subject to alter or accelerate his or her behavior. And researchers at Wharton think they may have found a key to getting more people vaccinated.

In a new study, released February 18, the study’s authors found that certain text messages resulted in 11% higher vaccination rates. The study was conducted by the Behavior Change for Good Initiative at the Wharton School and the School of Arts and Sciences of the University of Pennsylvania, in collaboration with the Penn Medicine Nudge Unit. They partnered with Walmart and two regional health systems and sent 19 different messages to 50,000 patients ahead of planned visits to their primary care providers in the fall of 2020. The messages were designed to spur patients to get a flu vaccine.

What they found was eye-opening. Precisely how a message was worded had a huge impact on whether the patient ended up getting the shot. The top performing message? Two reminder texts sent 72 hours and 24 hours before the appointment. “The first message encouraged patients to request a flu shot at their upcoming appointment to protect the health of themselves and their families, and the second reminded patients that a flu shot had been reserved for their appointment. In this study, the most effective messages were unsurprising and lacked interactive components–they simply reminded patients that a flu shot was reserved for them at their doctor’s office. Messages that were more clever or informal, such as sharing a joke about the flu, were less effective,” the study’s authors wrote.

As my colleague Erika Fry has reported, so far vaccinations have been unevenly distributed by state. “Through Tuesday, Feb. 16, 12.2% of the U.S. population, or 40.3 million people, had received at least one dose of a COVID vaccine, up from 33.8 million a week ago according to data from the Centers for Disease Control. And 15.5 million individuals, or 4.7% of the population, have been fully vaccinated with two doses of either the Pfizer or Moderna vaccines. In total, the country has administered 56.3 million doses, or 77.8% of the 72.4 million distributed,” Fry wrote.

As vaccines become more widely available, however, these nudges could help with wider uptake, or conceivably with populations that have shown a reluctance to get vaccinated.

The researchers are optimistic that that what they’ve learned about the flu will help with COVID. “Our results suggest a promising way to encourage COVID-19 vaccinations at scale—we can potentially help save lives for less than 10¢ per person,” said Katy Milkman, Wharton professor, BCFG Co-Director, and lead author on the study. In the end, said Mitesh Patel, Penn Medicine Professor and PMNU Director, such seemingly small tweaks could “nudge vaccination rates higher and help us end this pandemic faster.”

About the Author
By Lee CliffordExecutive Editor
LinkedIn icon

Lee Clifford is an Executive Editor at Fortune. Primarily she works with the Enterprise reporting team, which covers Tech, Leadership, and Finance as well as daily news and analysis from Fortune’s most experienced writers.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.